Stem cells, exosomes, gene therapy, peptides, hyperbaric oxygen, and epigenetic reprogramming
390 articles
A novel class of ferroptosis inhibitors protects donor organs from ischemia-reperfusion injury, potentially saving thousands of transplant patients annually.
A sweeping review maps every known strategy for delivering therapies directly to mitochondria, from lifestyle habits to nanocarriers and gene editing.
A critical review examines the engineering, materials, and biological challenges threatening the long-term reliability of implantable bioelectronic therapies.
Combining nanoparticles with mesenchymal stem cells could finally overcome the poor survival and differentiation that limits cartilage regeneration.
A new technique called PIVOT enables single-cell functional genetic screens in plants, opening doors to precision crop and botanical medicine research.
A translational review outlines how stem cell technologies may finally make hepatocyte-based liver therapies clinically viable.
Human stem cells that migrate through 3µm channels spontaneously begin differentiating into bone cells — no chemical signals required.
ProcyanidinC1, a natural senolytic, selectively eliminates senescent cells in diabetic skin, dramatically improving wound healing in mouse models.
A new review examines how umbilical cord-derived stem cells may repair dopaminergic neurons and slow Parkinson's progression beyond symptom relief.
A senolytic pairing of dasatinib and quercetin cleared senescent cells at the tendon-bone junction, dramatically improving repair strength in aged rats.
Packaging mitochondria in erythrocyte-derived membranes dramatically improves delivery efficiency, pushing this experimental therapy closer to clinical reality.
A novel anti-swelling hydrogel loaded with dasatinib, quercetin, and nucleus pulposus exosomes clears senescent cells and restores disc integrity in rats and goats.
